Tarsus Pharmaceuticals, Inc.
TARS
$46.47
$2.906.66%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -8.07% | -2.05% | 8.39% | 31.25% | -7.88% |
Total Receivables | 58.59% | -1.74% | -1.66% | 77.04% | 178.08% |
Inventory | -7.94% | 29.66% | -45.61% | 29.90% | 20,613.33% |
Prepaid Expenses | 108.84% | 17.46% | -12.22% | -13.54% | 30.98% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -0.12% | -1.51% | 6.42% | 33.03% | -1.21% |
|
|||||
Total Current Assets | -0.12% | -1.51% | 6.42% | 33.03% | -1.21% |
Net Property, Plant & Equipment | -31.68% | -0.36% | 21.33% | 3.64% | -7.64% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -2.81% | 133.62% | -2.65% | -2.59% | -2.52% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 78.14% | 1.24% | 156.57% | 2.17% | 9.24% |
Total Assets | 0.18% | -0.14% | 7.89% | 31.56% | -1.06% |
|
|||||
Total Accounts Payable | 3.45% | 0.61% | 39.24% | 7.71% | 71.18% |
Total Accrued Expenses | 21.74% | 84.73% | 32.61% | -53.82% | 60.39% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -3.65% | 4.30% | 3.42% | 46.98% | -5.91% |
Total Finance Division Other Current Liabilities | 45.92% | 43.65% | -3.55% | 236.59% | 28.82% |
Total Other Current Liabilities | 45.92% | 43.65% | -3.55% | 236.59% | 28.82% |
Total Current Liabilities | 22.38% | 27.72% | 21.26% | 15.14% | 58.87% |
|
|||||
Total Current Liabilities | 22.38% | 27.72% | 21.26% | 15.14% | 58.87% |
Long-Term Debt | 0.19% | 0.18% | 139.13% | 0.38% | 0.37% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -14.42% | -9.78% | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | 3,872.73% |
Total Liabilities | 9.83% | 11.41% | 68.22% | 8.12% | 25.31% |
|
|||||
Common Stock & APIC | 1.80% | 1.44% | 1.88% | 25.82% | 6.06% |
Retained Earnings | -6.86% | -7.47% | -11.87% | -14.60% | -20.67% |
Treasury Stock & Other | -48.27% | 296.59% | -179.37% | -3,050.00% | 75.00% |
Total Common Equity | -5.45% | -5.85% | -8.34% | 39.71% | -7.80% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -5.45% | -5.85% | -8.34% | 39.71% | -7.80% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -5.45% | -5.85% | -8.34% | 39.71% | -7.80% |
|